研究者業績

小澤 洋子

オザワ ヨウコ  (Ozawa Yoko)

基本情報

所属
藤田医科大学 臨床再生医学 教授
慶應義塾大学 医学部 眼科学教室 特任准教授
学位
医学博士(2004年6月 慶應義塾大学)

通称等の別名
小沢洋子
研究者番号
90265885
J-GLOBAL ID
200901062629077077
researchmap会員ID
5000088381

外部リンク

Yoko Ozawa M.D., Ph.D. works as a Chief of the Medical Retina Division (Age-related macular disease; AMD division) and a Vitreoretinal Surgeon, as well as a Lab Chief of the Laboratory of Retinal Cell Biology (RCB lab). Her recent research interest is the aging and neuroprotection of the retina, and its association with oxidative stress and inflammation. One of her missions is to find a neuroprotective treatment for the retinal diseases, such as AMD, diabetic retinopathy, and retinitis pigmentosa. During her training of the vitreoretinal surgery, she has become aware that simple surgical therapies do not always rescue the patients’ retina, and the additional approaches may be required for further improvement of the retinal conditions. Therefore, she joined a basic research lab, the Department of Physiology, Keio University School of Medicine, Prof. Hideyuki Okano’s Lab, for mastering neurobiology of the retina, including development and regeneration. After taking the Ph.D., she returned to Department of Ophthalmology, and started her research for learning the pathophysiology of the retinal diseases and exploring new therapeutic approaches.

学歴

 1

論文

 215
  • Mariko Sasaki, Kenya Yuki, Akiko Hanyuda, Kazumasa Yamagishi, Kaoru Motomura, Toshihide Kurihara, Yohei Tomita, Kiwako Mori, Nobuhiro Ozawa, Yoko Ozawa, Norie Sawada, Kazuno Negishi, Kazuo Tsubota, Shoichiro Tsugane, Hiroyasu Iso
    Scientific Reports 13(1) 2023年8月9日  
    Abstract Residents of Chikusei City, aged 40–74 years, underwent systemic and ophthalmological screening, and participants with diabetes were included in this analysis. Dietary intake was assessed using a food frequency questionnaire and calculated as a percentage of the total energy. The presence of diabetic retinopathy (DR) was defined as Early Treatment Diabetic Retinopathy Study levels ≥ 20 in either eye. The association between dietary fatty acid intake and DR has been examined in a cross-sectional study. Among the 647 diabetic participants, 100 had DR. The mean total fat and saturated fatty acid (SFA) intakes were 22.0% and 7.3% of the total energy intake, respectively. After adjusting for potential confounders, the highest quartiles of total fat and SFA intake were positively associated with the presence of DR compared with the lowest quartiles (odds ratios (95% confidence intervals), 2.61 (1.07–6.39), p for trend = 0.025, and 2.40 (1.12–5.17), p for trend = 0.013, respectively). No significant associations were found between DR prevalence and monounsaturated or unsaturated fatty acid intake. These results suggest that a high intake of fat and SFA may affect the development of DR, even in individuals whose total fat intake is generally much lower than that of Westerners.
  • Tomoyo Yasukawa, Mariko Sasaki, Kaoru Motomura, Kenya Yuki, Toshihide Kurihara, Yohei Tomita, Kiwako Mori, Nobuhiro Ozawa, Yoko Ozawa, Kazumasa Yamagishi, Akiko Hanyuda, Norie Sawada, Kazuo Tsubota, Shoichiro Tsugane, Hiroyasu Iso
    Translational vision science & technology 12(1) 3-3 2023年1月3日  
    PURPOSE: To determine the associations between fatty acid intakes and the prevalence of age-related macular degeneration (AMD) under a population-based cross-sectional study. METHODS: Residents of Chikusei City aged ≥40 years underwent systemic and eye screening. AMD was graded according to a modified version of the Age-Related Eye Disease Study classification. Dietary intake was assessed using a food frequency questionnaire and was adjusted for total energy intake. RESULTS: Altogether, 10,788 eyes of 5394 participants, 2116 men (mean [standard deviation (SD)] age, 62.4 [9.4] years) and 3278 women (60.6 [9.5] years), were included. The mean daily total fat intakes were 52.8 g and 59.0 g in men and women, respectively. After adjustments for potential confounders, saturated fatty acid (SFA) intake was inversely associated with the prevalence of any AMD in men (for each energy-adjusted 1-SD increase: odds ratio [OR], 0.86; 95% confidence interval [CI], 0.74-1.00). Significant trends were found for decreasing odds ratios of AMD with increasing SFA, monounsaturated fatty acid (MUFA), and polyunsaturated fatty acid (PUFA) intake (P for trend = 0.02, 0.04, and 0.04, respectively). In women, only a significant association was observed between the second quartile of linolenic acid intake and the prevalence of any AMD (OR, 0.78; 95% CI, 0.62-0.99). CONCLUSIONS: We found an inverse association of SFA intake and a weak inverse association of MUFA and PUFA intakes with the prevalence of any AMD in a Japanese population. TRANSLATIONAL RELEVANCE: Adequate fatty acid intake may be necessary to prevent or decelerate AMD.
  • Yoko Ozawa, Eriko Toda, Kohei Homma, Hideto Osada, Norihiro Nagai, Kazuo Tsubota, Hideyuki Okano
    Cells 11(9) 2022年4月29日  
    Retinitis pigmentosa (RP) is a hereditary blinding disease characterized by gradual photoreceptor death, which lacks a definitive treatment. Here, we demonstrated the effect of 4-phenylbutyric acid (PBA), a chemical chaperon that can suppress endoplasmic reticulum (ER) stress, in P23H mutant rhodopsin knock-in RP models. In the RP models, constant PBA treatment led to the retention of a greater number of photoreceptors, preserving the inner segment (IS), a mitochondrial- and ER-rich part of the photoreceptors. Electroretinography showed that PBA treatment preserved photoreceptor function. At the early point, ER-associated degradation markers, xbp1s, vcp, and derl1, mitochondrial kinetic-related markers, fis1, lc3, and mfn1 and mfn2, as well as key mitochondrial regulators, pgc-1α and tfam, were upregulated in the retina of the models treated with PBA. In vitro analyses showed that PBA upregulated pgc-1α and tfam transcription, leading to an increase in the mitochondrial membrane potential, cytochrome c oxidase activity, and ATP levels. Histone acetylation of the PGC-1α promoter was increased by PBA, indicating that PBA affected the mitochondrial condition through epigenetic changes. Our findings constituted proof of concept for the treatment of ER stress-related RP using PBA and revealed PBA's neuroprotective effects, paving the way for its future clinical application.
  • Ofuji Y*, Katada Y*, Tomita Y, Nagai N, Sonobe H, Watanabe K, Shinoda H, Ozawa Y, Negishi K, Tsubota K, Kurihara T†
    Life. 12(4) 542-542 2022年4月6日  査読有り
  • Naohiko Aketa, Miki Uchino, Motoko Kawashima, Yuichi Uchino, Kenya Yuki, Yoko Ozawa, Mariko Sasaki, Kazumasa Yamagishi, Norie Sawada, Shoichiro Tsugane, Kazuo Tsubota, Hiroyasu Iso
    Scientific Reports 11(1) 2021年12月  
    <title>Abstract</title>This population-based cross-sectional study was performed to determine the mean corneal endothelial cell density (ECD), coefficient of variation (CV), and hexagonality (HEX), and their associations with myopia in Japanese adults living in Chikusei city. Of 7109 participants with available data, 5713 (2331 male and 3382 female) participants were eligible for analysis. After assessing the relationship between participant characteristics and spherical equivalent refraction (SER), the association of SER with the abnormal value of ECD (&lt; 2000 cells/mm), CV (≥ 0.40), and HEX (≤ 50%) were determined using the logistic regression models adjusting for potential confounders (age, intraocular pressure, keratometric power, height, and antihypertensive drug use). In male participants, there was no statistically significant relationships between SER and endothelial parameters. In female participants, compared to emmetropia, SER ≤ − 6 D had significantly higher odds ratio (OR) of having the abnormal value of CV (OR = 2.07, 95% confidence interval [CI] 1.39–3.10) and HEX (OR = 2.04, 95% CI 1.29–3.23), adjusted for potential confounders, indicating that the high myopia was associated with the abnormal values of CV and HEX. Further adjustment for contact lenses wear partly attenuated these associations. Association between the SER and ECD was not detected.

MISC

 82
  • Hirohiko Kawashima, Yoko Ozawa, Eriko Toda, Kohei Homma, Hideto Osada, Toshio Narimatsu, Norihiro Nagai, Kazuo Tsubota
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34(4) 5016-5026 2020年4月  
    Progression of blinding diseases, such as age-related macular degeneration, is accelerated by light exposure. However, no particular intervention is applied to the photostress. Here, we report neuroprotective effects of the adenosine monophosphate (AMP)-activated protein kinase (AMPK) activator, 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR), on light-induced visual function impairment, photoreceptor disorders and death in mice. Increase in retinal ATP levels in response to photostress was transient, because oxygen consumption rate (OCR) and cytochrome c oxidase (CcO) activity were reduced under photostress. However, AICAR treatment preserved OCR, CcO activity, and high levels of retinal ATP after light exposure. AMPK knockdown in the photoreceptor-derived cell line revealed that AMPK targeted CcO activity. Further, our data indicated that photostress reduced mitochondrial respiratory function and ATP levels, while AICAR treatment promoted neuronal survival and retained visual function, stabilizing ATP levels through preserved CcO activity. The current study has provided proof of concept for providing cells with sufficient energy to promote cell survival in the presence of cellular stress. This is in contrast to the previous reports which primarily investigated therapeutic approaches to suppress stress signals. Hence, stabilization of the ATP supply may serve as a novel therapeutic approach to support tissue survival under stress and prevent neurodegeneration.
  • 佐藤真帆, 永井紀博, 鈴木美砂, 南早紀子, 栗原俊英, 園部秀樹, 渡邊一弘, 篠田肇, 坪田一男, 小沢洋子
    日本眼科学会雑誌 123 2019年  
  • 平沢学, 平沢学, 戸田枝里子, 長田秀斗, 三宅誠司, 尾池雄一, 坪田一男, 小沢洋子
    日本眼科学会雑誌 121 308 2017年3月8日  
  • 坪田 一男, 根岸 一乃, 榛村 重人, 小川 葉子, 村戸 ドール, 羽藤 晋, 小沢 洋子, 綾木 雅彦, 中村 滋, 川島 素子, 栗原 俊英, 羽鳥 恵, 川北 哲也, 樋口 明弘, 井上 佐智子, 海道 美奈子, 石田 玲子, Connell Samuel, Vu Chi Hoang Viet, Ibrahim Osama, Mohamed Aly, 久村 隆二, 今田 敏博, 稲葉 隆明, 泉田 祐輔, 小島 隆司, きん 楷, 向井 慎, 佐野 こころ, 柳 櫻, 比嘉 一成, 稲垣 絵海, 鳥居 秀成, 堅田 侑作, 三輪 幸裕, 森 紀和子, 姜 效炎, 篠田 肇, 永井 紀博, 久保田 俊介, 久保田 みゆき, 芝 大介, 結城 賢弥, 内田 敦郎, 成松 俊雄, 伴 紀充, 鴨下 衛, 戸田 郁子, 井手 武, 三木 恵美子, 荒井 宏幸, 加藤 圭一, 原 裕, 原 道子, 渡辺 光博, 福田 真嗣, 山中 章弘, 世古 裕子, 中村 孝博, Apte Rajendra, Lin Jonathan, 今井 眞一郎
    日本眼科学会雑誌 121(3) 232-248 2017年3月  
    緑内障,加齢黄斑変性をはじめとしてドライアイなど眼疾患の大部分は加齢によって罹患率が上昇する加齢関連疾患である.また網膜色素変性症や近視も遺伝の素因があるものの,加齢によって病態が進行することから加齢関連疾患ともいえる.そこで個々の疾患一つひとつをターゲットにするのではなく,加齢そのものにチャレンジして結果的に眼疾患を治療するという新たなアプローチが始まっている.現在の抗加齢アプローチの基本はカロリー制限(CR)であり,さまざまなメカニズムを介して抗酸化酵素など長寿にプラスになる遺伝子群の誘導を行い健康にプラスに働くと考えられている.まずは酸化ストレスと眼疾患の関係だが,Cu,Zn-superoxide dismutase-1(Sod-1)ノックアウトマウス,Mev1トランスジェニックマウス,Nrf-2ノックアウトマウスなど酸化ストレスが増大する遺伝子改変マウスや,喫煙などの酸化ストレス増大状態では,涙液分泌が減少しドライアイを発症することを確認した.近年,マイクロバイオームが注目を集めているが,ドライアイ研究においてもラクトフェリンや乳酸菌サプリメントなどによって涙腺の酸化ストレスを減少させることが分かり,涙液を増大させるサプリメントとして臨床に使われるようになった.CRによって長寿遺伝子サーチュインが活性化するが,CRによって涙液分泌が増大し,またサーチュインを活性化するレスベラトロールやnicotinamide mononucleotide(NMN)によって網膜保護が可能なことを示した.特にNMNについては網膜色素変性症の抑制に効果がある可能性があり期待されている.また,CRの第2の経路といわれるケトン体点眼薬を開発したところCRと同じ効果があることが分かり,新しいドライアイ治療法や網膜,視神経の保護薬として臨床開発中である.その他の経路としては免疫老化の観点から小胞体ストレスの抑制,低酸素誘導因子(HIF)の抑制,インスリン様成長因子(IGF)経路の抑制などがあり,これらのすべての経路を介するアンチエイジングアプローチが始まっている.以上のように抗加齢という新しい戦略による眼疾患へのアプローチが始まりつつある.現在の医療費増大に対して予防医学の導入が叫ばれて久しいが,抗加齢アプローチはまさに加齢に注目した次世代の予防医学と考えられ,大きな期待が寄せられている.(著者抄録)
  • 杉田 直, 石田 晋, 小沢 洋子
    Retina medicine : journal of retina medeicine : 網膜・硝子体領域を中心とした医学情報誌 6(2) 140-144 2017年  

書籍等出版物

 3

講演・口頭発表等

 53

担当経験のある科目(授業)

 4

共同研究・競争的資金等の研究課題

 27